Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
A heterocycloalkynylbenzimide-based dual DDR1/DDR2 inhibitor could be used to probe the role of two proteins in inflammatory diseases. Chemical synthesis and in vitro activity assays of heterocycloalk...
BCIQ Company Profiles
Jinan University
Wenzhou Medical University
BCIQ Target Profiles
Discoidin domain receptor tyrosine kinase 1 (DDR1)
Discoidin domain receptor tyrosine kinase 2 (DDR2)